Skip to content
Back to recalls
Drug FDA Class II Ongoing Foreign material

Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.

Teva Pharmaceuticals USA, Inc Published Jul 2, 2025

Risk level

Class II

May cause a temporary or reversible health problem; slight chance of serious harm.

Severity score 60/100

What should you do?

  • Check whether you have this product, using the lot codes, UPCs, and dates listed below.
  • Do not eat, serve, or sell the affected product.
  • Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
  • Contact Teva Pharmaceuticals USA, Inc or your place of purchase with questions, and see the source record below for full details.
Reason for recall

Presence of foreign tablets/capsules.

Hazards

Foreign Tablets/Capsules · primary

Affected products (1)

Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.

METOCLOPRAMIDE · 36612 cartons

NDC: 0093-2203, 0093-2204, 0093-2204-01, 0093-2204-05, 0093-2203-01, 0093-2203-05, 0093-2203-10
Code info: Lot#: 5420094, Exp 09/30/2027

Affected areas

Nationwide

Timeline

  1. Initiated
    May 23, 2025
  2. Published
    Jul 2, 2025
Recall number
D-0473-2025
Agency
U.S. Food and Drug Administration
Country
US
Source data (openFDA JSON) About FDA enforcement reports

FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.